These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36537205)

  • 1. The War on Drugs has Unduly Biased Substance Use Research.
    Stone BM
    Psychol Rep; 2024 Aug; 127(4):2087-2094. PubMed ID: 36537205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recovery schools for improving behavioral and academic outcomes among students in recovery from substance use disorders: a systematic review.
    Hennessy EA; Tanner-Smith EE; Finch AJ; Sathe N; Kugley S
    Campbell Syst Rev; 2018; 14(1):1-86. PubMed ID: 37131375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of knowledge on attitudes of emergency department staff towards patients with substance related presentations: a quantitative systematic review protocol.
    Clarke DE; Gonzalez M; Pereira A; Boyce-Gaudreau K; Waldman C; Demczuk L
    JBI Database System Rev Implement Rep; 2015 Oct; 13(10):133-45. PubMed ID: 26571289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Substance use, affective problems and personality traits: test of two association models].
    Chakroun N; Doron J; Swendsen J
    Encephale; 2004; 30(6):564-9. PubMed ID: 15738859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acting out and psychoactive substances: alcohol, drugs, illicit substances].
    Gillet C; Polard E; Mauduit N; Allain H
    Encephale; 2001; 27(4):351-9. PubMed ID: 11686057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Weighing the benefits and harms of psychotropic and analgesic substances - A perspective of German addiction medicine experts].
    Bonnet U; Specka M; Soyka M; Alberti T; Bender S; Hilger J; Hillemacher T; Kuhlmann T; Kuhn J; Lüdecke C; Reimer J; Schneider U; Schroeder W; Stuppe M; Wiesbeck G; Wodarz N; Scherbaum N
    Fortschr Neurol Psychiatr; 2022 Jan; 90(1-02):19-29. PubMed ID: 33634461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender differences in prevalence of substance use disorders among individuals with lifetime exposure to substances: results from a large representative sample.
    Lev-Ran S; Le Strat Y; Imtiaz S; Rehm J; Le Foll B
    Am J Addict; 2013 Jan; 22(1):7-13. PubMed ID: 23398220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there heterogeneity among syndromes of substance use disorder for illicit drugs?
    Beseler C; Jacobson KC; Kremen WS; Lyons MJ; Glatt SJ; Faraone SV; Gillespie NA; Tsuang MT
    Addict Behav; 2006 Jun; 31(6):929-47. PubMed ID: 16697532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges to Studying Illicit Drug Users.
    Ryan JE; Smeltzer SC; Sharts-Hopko NC
    J Nurs Scholarsh; 2019 Jul; 51(4):480-488. PubMed ID: 31106524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors Influencing Stigma Toward Individuals Who Have Substance Use Disorders.
    Witte TH; Wright A; Stinson EA
    Subst Use Misuse; 2019; 54(7):1115-1124. PubMed ID: 30693812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-reported psychotic disorders among Individuals with substance use disorders: findings from the National Epidemiologic Survey on Alcohol and Related Conditions.
    Lev-Ran S; Imtiaz S; Le Foll B
    Am J Addict; 2012; 21(6):531-5. PubMed ID: 23082831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adult attention-deficit/hyperactivity disorder and its association with substance use and substance use disorders in young men.
    Estévez N; Dey M; Eich-Höchli D; Foster S; Gmel G; Mohler-Kuo M
    Epidemiol Psychiatr Sci; 2016 Jun; 25(3):255-66. PubMed ID: 25989844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substituting cannabis for prescription drugs, alcohol and other substances among medical cannabis patients: The impact of contextual factors.
    Lucas P; Walsh Z; Crosby K; Callaway R; Belle-Isle L; Kay R; Capler R; Holtzman S
    Drug Alcohol Rev; 2016 May; 35(3):326-33. PubMed ID: 26364922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A peer-delivered intervention to reduce harm and improve the well-being of homeless people with problem substance use: the SHARPS feasibility mixed-methods study.
    Parkes T; Matheson C; Carver H; Foster R; Budd J; Liddell D; Wallace J; Pauly B; Fotopoulou M; Burley A; Anderson I; MacLennan G
    Health Technol Assess; 2022 Feb; 26(14):1-128. PubMed ID: 35212621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of a participatory needs assessment demonstrate an opportunity to involve people who use alcohol in drug user activism and harm reduction.
    Crabtree A; Latham N; Bird L; Buxton J
    Harm Reduct J; 2016 Dec; 13(1):37. PubMed ID: 27938376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substance use and homelessness: A longitudinal interview study conducted during COVID-19 with implications for policy and practice.
    Neale J; Parkin S; Hermann L; Metrebian N; Roberts E; Robson D; Strang J
    Int J Drug Policy; 2022 Oct; 108():103818. PubMed ID: 35961238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial evidence of reliability and validity of an implicit association test assessing attitudes toward individuals who use substances.
    Benau EM; Zavodnick JH; Jaffe RC
    Am J Drug Alcohol Abuse; 2024 Jan; 50(1):64-74. PubMed ID: 38295383
    [No Abstract]   [Full Text] [Related]  

  • 19. A systematic review of the effectiveness of digital interventions for illicit substance misuse harm reduction in third-level students.
    Dick S; Whelan E; Davoren MP; Dockray S; Heavin C; Linehan C; Byrne M
    BMC Public Health; 2019 Sep; 19(1):1244. PubMed ID: 31500618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stress Allostasis in Substance Use Disorders: Promise, Progress, and Emerging Priorities in Clinical Research.
    Fronk GE; Sant'Ana SJ; Kaye JT; Curtin JJ
    Annu Rev Clin Psychol; 2020 May; 16():401-430. PubMed ID: 32040338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.